Recovery After Stress Toolkit (RESET) Study (ReSeT)

August 12, 2025 updated by: University of Utah

Pediatric Injury: Modules to Manage Medical Stress

This study evaluates the use of web-based educational modules combined with telehealth delivered therapy for children with post-traumatic stress symptoms (PTSS) after receiving hospital based medical attention for an injury. Half of the participants will received the online therapy and half of the participants will receive usual care.

Study Overview

Detailed Description

As many as 30% of children develop post-traumatic stress symptoms after an injury. Post-traumatic stress symptoms can decrease children's quality of life. Psychological distress may emerge after the child is discharged from the hospital and may go unrecognized. Cognitive behavioral therapy and graduated exposures are standard treatments for PTSS.

Study Type

Interventional

Enrollment (Actual)

93

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45056
        • Cincinnati Children's Hospital
    • Texas
      • Houston, Texas, United States, 77030
        • University of Texas Health Sciences Center
    • Utah
      • Salt Lake City, Utah, United States, 84101
        • University of Utah

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 17 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 8 years to 17 years at enrollment
  • Treated for an injury in the ED or hospitalized
  • Abbreviated Injury Scale (AIS) score 2 or greater
  • Parent and child English speaking
  • Broad band internet availability at home
  • Residing with parent or legal guardian

Exclusion Criteria:

  • Moderate or severe traumatic brain injury (GCS less than 13)
  • Diagnosed with moderate or severe intellectual disability
  • Pre-existing psychiatric disorder that required hospitalization
  • Abuse or interpersonal injury as mechanism of injury
  • Currently receiving psychotherapy
  • Hospitalized for injury over 30 ays
  • Death of a family member or friend at time of injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: RESET
Children will view 8 educational modules online and participate in 8 sessions with a therapist via telehealth.
Therapy
No Intervention: Control
Children will receive usual post-trauma care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child PTSD Symptom Scale (CPSS)
Time Frame: 10 weeks post-randomization
17 items listing potential PTSD symptoms scored on a Likert scale of 0 to 3 with 0=Not at all and 3= 5 or more times a week. 7 additional yes/no questions ask if problems interfered with various activities. Higher score is worse. Range 0 to 80. We used the combined child report and parent report. The highest item score from either parent or child was summed.
10 weeks post-randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Screen for Anxiety Related Emotional Disorders (SCARED)
Time Frame: 10 weeks post-randomization
41-item survey with three point Likert scale responses (not sure, somewhat true, very true) that asks about common difficulties for children with anxiety. Higher scores indicate worse outcomes. Range 0-82
10 weeks post-randomization
Patient Reported Outcome Measurement Information System (PROMIS) Pediatric Depressive Symptoms
Time Frame: 10-weeks post-randomization
PROMIS pediatric item bank : 8 questions with a 5-point Likert response from Never to Almost Always. Higher scores means more depressive symptoms. T-score with mean = 50; Standard Deviation (SD)=10.
10-weeks post-randomization
Pediatric Quality of Life Inventory (PedsQL)
Time Frame: 10-weeks
15 question scale based on physical, emotional, social and school functioning answered on a 5-point Likert scale (never to almost always). Score is 0 - 100 with higher scores indicating better HRQoL. Parent proxy scale.
10-weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Connor David Resilience Scale
Time Frame: 10-weeks
10-item scale with LIkert response from 0 - not true to 4=true nearly all of the time. Range is 0 to 40 with higher scores indicating more resilience (better).
10-weeks
PROMIS Pediatric Anger
Time Frame: 10-weeks post-randomization
5 question PROMIS measure answered with a 5-point Likert scale. A higher score indicates more anger (worse). T-score with mean = 50; SD = 10.
10-weeks post-randomization
PROMIS Pediatric Psychological Stress Experience
Time Frame: 10-weeks post-randomization
8-question PROMIS measure answered with a 5-point Likert scale. A higher score is more stress (worse). T-score with mean 50; SD 10.
10-weeks post-randomization
PROMIS Pediatric Physical Stress Experience
Time Frame: 10-weeks
8-question PROMIS measure answered on a 5-point Likert scale. A higher score is more physical stress (worse). T-score with mean 50; SD 10.
10-weeks
PROMIS Pediatric Anxiety
Time Frame: 10-weeks
8-question PROMIS measure answered on a 5-point LIkert scale. A higher score is more anxiety (worse). T-score with mean 50; SD 10.
10-weeks
PROMIS Pediatric Global Health
Time Frame: 10-weeks
Seven questions about global health with 5-point Likert response from excellent to poor. A higher score is more poor health (worse). T-score with mean 50; SD 10.
10-weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heather T Keenan, MDCM, University of Utah

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 23, 2021

Primary Completion (Actual)

January 18, 2024

Study Completion (Actual)

September 5, 2024

Study Registration Dates

First Submitted

March 30, 2021

First Submitted That Met QC Criteria

April 8, 2021

First Posted (Actual)

April 9, 2021

Study Record Updates

Last Update Posted (Estimated)

August 28, 2025

Last Update Submitted That Met QC Criteria

August 12, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • HD096350
  • R24HD096350 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual de-identified participant data underlying the trial will be made available 3 years after the last enrolled subject has completed all procedures to investigators who provide a methodologically sound proposal.

IPD Sharing Time Frame

36 months after last subject has completed all procedures. Data will be available for 36 months.

IPD Sharing Access Criteria

Investigators who provide a methodologically sound proposal

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Traumatic Stress Disorder in Children

Clinical Trials on RESET

Subscribe